and...
Interest from prospective partners spans products and technology
- ArTiMist™ sub--lingual spray for malaria
- SUDA’s clinical-stage oral sprays for migraine, nausea, and erectile dysfuncion
- Applicaion of our technology to reformulate other drugs (lifecycle management)
shareholder update, page-2
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.010(6.06%) |
Mkt cap ! $183.9M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.5¢ | 16.5¢ | $460.1K | 2.614M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 255235 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 189078 | 5 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| ALA (ASX) Chart |